Search by Drug Name or NDC
NDC 00132-0211-36 PHAZYME 250 mg/1 Details
PHAZYME 250 mg/1
PHAZYME is a ORAL CAPSULE, GELATIN COATED in the HUMAN OTC DRUG category. It is labeled and distributed by C.B. Fleet Company, Inc.. The primary component is DIMETHICONE.
MedlinePlus Drug Summary
Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00132-0211-36Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Simethicone
Product Information
| NDC | 00132-0211 |
|---|---|
| Product ID | 0132-0211_f916cbab-92e9-46a7-aea1-df2dac2e05b2 |
| Associated GPIs | 52200020000145 |
| GCN Sequence Number | 024814 |
| GCN Sequence Number Description | simethicone CAPSULE 250 MG ORAL |
| HIC3 | D4N |
| HIC3 Description | ANTIFLATULENTS |
| GCN | 09274 |
| HICL Sequence Number | 001224 |
| HICL Sequence Number Description | SIMETHICONE |
| Brand/Generic | Brand |
| Proprietary Name | PHAZYME |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Simethicone |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CAPSULE, GELATIN COATED |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIMETHICONE |
| Labeler Name | C.B. Fleet Company, Inc. |
| Pharmaceutical Class | Skin Barrier Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part332 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00132-0211-36 (00132021136)
| NDC Package Code | 0132-0211-36 |
|---|---|
| Billing NDC | 00132021136 |
| Package | 3 BLISTER PACK in 1 BOX (0132-0211-36) / 12 CAPSULE, GELATIN COATED in 1 BLISTER PACK |
| Marketing Start Date | 2014-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |